The 20th National Innovation Award ceremony took place at the end of 2023. In front of a distinguished audience of 1200 experts, AeproMED had the opportunity to share insights about their company.
AeproMED has developed an intelligent inhalation platform that overcomes issues associated with traditional drug conversion into uneven aerosol particles. This innovation also reduces drug residue and heat effects, contributing to the stability of drug molecules.
Leveraging AeporMED’s AFDT and DSMT technologies, we can deliver drugs to particular areas in the lungs. We look forward to collaborating with more biotech and pharmaceutical companies in the future, aiming to collectively pioneer new inhalation applications for the benefit of a wider range of patients.
[The 20th National innovation Award Report]
[More Instant FB News Link]
